Drug Research
India’s first mRNA Covid vaccine by Gennova granted approval for Phase 2/3 clinical trails
India’s first mRNA-based COVID-19 vaccine candidate HGCO19 by Gennova Biopharmaceuticals Ltd has been granted approval for Phase 2/3 clinical trials, the Department of Biotechnology (DBT) said.
The Pune-based biotechnology company had submitted the interim clinical data of the vaccine’s Phase...
News
Sorrento’s Covid-19 vaccine induces robust immune responses in studies
Sorrento Therapeutics, Inc., a clinical and commercial stage biopharmaceutical company developing new therapies to treat cancer, pain and COVID-19. The publication details preclinical vaccination studies of a new to-be-licensed and developed protein-based COVID-19 vaccination candidate, DYAI-100. The new RBD-based...
News
US FDA approves Jardiance to treat adults living with heart failure with reduced ejection fraction
Jardiance® (empagliflozin) 10 mg has been approved by the U.S. Food and Drug Administration to reduce the risk of cardiovascular death plus hospitalization for heart failure in adults with heart failure with reduced ejection fraction (HFrEF), Boehringer Ingelheim and...
News
DKSH Selected as Medigen’s COVID-19 Vaccine Distribution Partner in Taiwan
DKSH Business Unit Healthcare has entered into a partnership with Medigen Vaccine Biologics Corporation to ensure that their COVID-19 vaccines are speedily delivered and well protected throughout the entire cold chain.
DKSH Business Unit Healthcare, the leading partner for healthcare...
Drug Research
BMS obtains FDA approval for Opdivo as bladder cancer treatment
The US FDA has approved Bristol Myers Squibb’s (BMS) Opdivo (nivolumab) as an adjuvant therapy for urothelial carcinoma (UC) patients at increased risk of recurrence following radical resection.
A programmed death-1 (PD-1) immune checkpoint inhibitor, Opdivo can specifically harness the...
Drug Research
McMaster, Sartorius Enter Biomanufacturing Partnership
Sartorius Stedim Biotech, an international partner of the biopharmaceutical industry, has entered into a partnership with McMaster University to improve manufacturing processes of antibody and virus-based treatments for diseases such as COVID-19, cancers and genetic disorders.
Using a state-of-the-art multi-column...
News
Clinerion patent for technology underpinning Patient Network Explorer is published
The new Clinerion patent underpins any medical EHR database infrastructure that incorporates a hybrid model of cloud-and-local server node installations at individual hospitals, as well as any method for search of patient cohort care metrics across such a platform....
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read